InvestorsHub Logo
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

Re: NY1972 post# 1170

Thursday, 10/29/2015 8:47:55 AM

Thursday, October 29, 2015 8:47:55 AM

Post# of 2944

If Harvoni will remain GILD’s preferred treatment for GT1 patients, what impact this 12-week regimen of Sovaldi/Velpatasvir will have on V Pak?

Little, if any effect, IMO; in the US, V-Pak is approved only for GT1, and Technivive (a 2-DAA subset of V-Pak) is approved only for GT4.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News